Equities

Wai Yuen Tong Medicine Holdings Ltd

Wai Yuen Tong Medicine Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.195
  • Today's Change0.002 / 1.04%
  • Shares traded860.00k
  • 1 Year change+93.41%
  • Beta0.2342
Data delayed at least 15 minutes, as of Sep 20 2024 08:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments197579645
Total Receivables, Net217195176
Total Inventory3081,6371,869
Prepaid expenses125232
Other current assets, total96239167
Total current assets8302,7022,889
Property, plant & equipment, net665961956
Goodwill, net------
Intangibles, net------
Long term investments1873,3043,723
Note receivable - long term3801713
Other long term assets------
Total assets2,0957,0147,598
LIABILITIES
Accounts payable317986
Accrued expenses5.218389
Notes payable/short-term debt000
Current portion long-term debt/capital leases284732763
Other current liabilities, total61763942
Total current liabilities3811,6571,881
Total long term debt2761,0321,041
Total debt5601,7651,804
Deferred income tax1.36569642
Minority interest(1.49)1,3391,445
Other liabilities, total516673
Total liabilities7084,6655,082
SHAREHOLDERS EQUITY
Common stock121212
Additional paid-in capital1,1332,0972,107
Retained earnings (accumulated deficit)221113156
Treasury stock - common------
Unrealized gain (loss)28104104
Other equity, total(6.38)23137
Total equity1,3872,3492,516
Total liabilities & shareholders' equity2,0957,0147,598
Total common shares outstanding1,1711,2051,232
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.